305 related articles for article (PubMed ID: 35514606)
1. Temporal trends of sex differences for COVID-19 infection, hospitalisation, severe disease, intensive care unit (ICU) admission and death: a meta-analysis of 229 studies covering over 10M patients.
Pijls BG; Jolani S; Atherley A; Dijkstra JIR; Franssen GHL; Hendriks S; Yi-Wen Yu E; Zalpuri S; Richters A; Zeegers MP
F1000Res; 2022; 11():5. PubMed ID: 35514606
[No Abstract] [Full Text] [Related]
2. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies.
Pijls BG; Jolani S; Atherley A; Derckx RT; Dijkstra JIR; Franssen GHL; Hendriks S; Richters A; Venemans-Jellema A; Zalpuri S; Zeegers MP
BMJ Open; 2021 Jan; 11(1):e044640. PubMed ID: 33431495
[TBL] [Abstract][Full Text] [Related]
3. Ethnic minority status as social determinant for COVID-19 infection, hospitalisation, severity, ICU admission and deaths in the early phase of the pandemic: a meta-analysis.
Agyemang C; Richters A; Jolani S; Hendriks S; Zalpuri S; Yu E; Pijls B; Prins M; Stronks K; Zeegers MP
BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34740916
[TBL] [Abstract][Full Text] [Related]
4. Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis.
Vai B; Mazza MG; Delli Colli C; Foiselle M; Allen B; Benedetti F; Borsini A; Casanova Dias M; Tamouza R; Leboyer M; Benros ME; Branchi I; Fusar-Poli P; De Picker LJ
Lancet Psychiatry; 2021 Sep; 8(9):797-812. PubMed ID: 34274033
[TBL] [Abstract][Full Text] [Related]
5. Racial and Ethnic Disparities in Rates of COVID-19-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death in the United States From March 2020 to February 2021.
Acosta AM; Garg S; Pham H; Whitaker M; Anglin O; O'Halloran A; Milucky J; Patel K; Taylor C; Wortham J; Chai SJ; Kirley PD; Alden NB; Kawasaki B; Meek J; Yousey-Hindes K; Anderson EJ; Openo KP; Weigel A; Monroe ML; Ryan P; Reeg L; Kohrman A; Lynfield R; Bye E; Torres S; Salazar-Sanchez Y; Muse A; Barney G; Bennett NM; Bushey S; Billing L; Shiltz E; Sutton M; Abdullah N; Talbot HK; Schaffner W; Ortega J; Price A; Fry AM; Hall A; Kim L; Havers FP
JAMA Netw Open; 2021 Oct; 4(10):e2130479. PubMed ID: 34673962
[TBL] [Abstract][Full Text] [Related]
6. Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis.
Fernández Villalobos NV; Ott JJ; Klett-Tammen CJ; Bockey A; Vanella P; Krause G; Lange B
Syst Rev; 2021 Jun; 10(1):194. PubMed ID: 34193261
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019-positive patients.
Hu FH; Jia YJ; Zhao DY; Fu XL; Zhang WQ; Tang W; Hu SQ; Wu H; Ge MW; Du W; Shen WQ; Zhu B; Chen HL
Clin Microbiol Infect; 2023 Jul; 29(7):835-844. PubMed ID: 36934872
[TBL] [Abstract][Full Text] [Related]
8. Severe Outcomes Associated With SARS-CoV-2 Infection in Children: A Systematic Review and Meta-Analysis.
Sumner MW; Kanngiesser A; Lotfali-Khani K; Lodha N; Lorenzetti D; Funk AL; Freedman SB
Front Pediatr; 2022; 10():916655. PubMed ID: 35757137
[TBL] [Abstract][Full Text] [Related]
9. Risks of infection, hospital and ICU admission, and death from COVID-19 in people with asthma: systematic review and meta-analyses.
Otunla A; Rees K; Dennison P; Hobbs R; Suklan J; Schofield E; Gunnell J; Mighiu A; Hartmann-Boyce J
BMJ Evid Based Med; 2022 Oct; 27(5):263-273. PubMed ID: 34933924
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-Analysis.
Conway R; Grimshaw AA; Konig MF; Putman M; Duarte-García A; Tseng LY; Cabrera DM; Chock YPE; Degirmenci HB; Duff E; Egeli BH; Graef ER; Gupta A; Harkins P; Hoyer BF; Jayatilleke A; Jin S; Kasia C; Khilnani A; Kilian A; Kim AHJ; Lin CMA; Low C; Proulx L; Sattui SE; Singh N; Sparks JA; Tam H; Ugarte-Gil MF; Ung N; Wang K; Wise LM; Yang Z; Young KJ; Liew JW; Grainger R; Wallace ZS; Hsieh E;
Arthritis Rheumatol; 2022 May; 74(5):766-775. PubMed ID: 34807517
[TBL] [Abstract][Full Text] [Related]
11. Effects of SARS-CoV-2 infections in patients with cancer on mortality, ICU admission and incidence: a systematic review with meta-analysis involving 709,908 participants and 31,732 cancer patients.
Arayici ME; Kipcak N; Kayacik U; Kelbat C; Keskin D; Kilicarslan ME; Kilinc AV; Kirgoz S; Kirilmaz A; Kizilkaya MA; Kizmaz IG; Kocak EB; Kochan E; Kocpinar B; Kordon F; Kurt B; Ellidokuz H
J Cancer Res Clin Oncol; 2023 Jul; 149(7):2915-2928. PubMed ID: 35831763
[TBL] [Abstract][Full Text] [Related]
12. Association of Nonsteroidal Anti-inflammatory Drug Use and Adverse Outcomes Among Patients Hospitalized With Influenza.
Lund LC; Reilev M; Hallas J; Kristensen KB; Thomsen RW; Christiansen CF; Sørensen HT; Johansen NB; Brun NC; Voldstedlund M; Støvring H; Thomsen MK; Christensen S; Pottegård A
JAMA Netw Open; 2020 Jul; 3(7):e2013880. PubMed ID: 32609352
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 Outcomes in Patients With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A US Multicenter, Comparative Cohort Study.
D'Silva KM; Jorge A; Cohen A; McCormick N; Zhang Y; Wallace ZS; Choi HK
Arthritis Rheumatol; 2021 Jun; 73(6):914-920. PubMed ID: 33305544
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 and COVID-19 in diabetes mellitus. Population-based study on ascertained infections, hospital admissions and mortality in an Italian region with ∼5 million inhabitants and ∼250,000 diabetic people.
Bonora E; Fedeli U; Schievano E; Trombetta M; Saia M; Scroccaro G; Tacconelli E; Zoppini G
Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2612-2618. PubMed ID: 34348880
[TBL] [Abstract][Full Text] [Related]
15. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
16. Trends in the morbidity and mortality of coronavirus disease 2019 in different ethnic groups and gender in a large Brazilian city.
Nascimento JHFD; Andrade AB; Gusmão-Cunha A; Cunha AMG
J Med Virol; 2023 May; 95(5):e28794. PubMed ID: 37212257
[TBL] [Abstract][Full Text] [Related]
17. The role of plant-based dietary patterns in reducing COVID-19 risk and/or severity in adults: A systematic review and meta-analysis of observational studies.
Papadaki A; Coy EM; Anastasilakis DA; Peradze N; Mantzoros CS
Clin Nutr; 2024 Jul; 43(7):1657-1666. PubMed ID: 38810425
[TBL] [Abstract][Full Text] [Related]
18. Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea.
Seon JY; Jeon WH; Bae SC; Eun BL; Choung JT; Oh IH
J Korean Med Sci; 2021 May; 36(20):e148. PubMed ID: 34032033
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Clinical Features of Hospitalized Patients Due to the SARS-CoV-2 Infection in the Absence of Comorbidities Regarding the Sex: An Epidemiological Study of the First Year of the Pandemic in Brazil.
Sansone NMS; Pereira LR; Boschiero MN; Valencise FE; Fraga AMA; Marson FAL
Int J Environ Res Public Health; 2022 Jul; 19(15):. PubMed ID: 35897265
[TBL] [Abstract][Full Text] [Related]
20. Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
Lund LC; Kristensen KB; Reilev M; Christensen S; Thomsen RW; Christiansen CF; Støvring H; Johansen NB; Brun NC; Hallas J; Pottegård A
PLoS Med; 2020 Sep; 17(9):e1003308. PubMed ID: 32898149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
